ERBB3 and neoplasm: The association of HER3 with brain metastasis21 led us to test whether HER3 can transport systemic NBPs across the BBB and into intracerebral TNBC tumours and reduce tumour growth when delivering tumoricidal agents compared with currently used clinical therapy and traditional BBB crossing agents.